BOAN Biotech Schedules 27 Aug 2026 Board Meeting to Approve 1H26 Results and Assess Interim Dividend

Bulletin Express

Aug 14

Shandong Boan Biotechnology Co., Ltd. (BOAN Biotech) has announced that its board of directors will convene on 27 August 2026 to review and approve the company’s interim financial results for the six months ended 30 June 2026. The agenda also includes deliberation on the declaration of an interim dividend, if any.

The notice, dated 14 August 2026 and signed by Chairlady and CEO Jiang Hua, confirms that decisions regarding the interim results release and potential dividend distribution will be finalized at this meeting. Investors should expect publication of the approved interim report following the board’s deliberations.

The current Board comprises two executive directors (Jiang Hua and Wang Shenghan), three non-executive directors (Liu Yuanchong, Li Li and Li Shixu), and three independent non-executive directors (Professor Shi Luwen, Dai Jixiong and Dr. Yu Jialin).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1157713669"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1157713669\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1157713669?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-14 22:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1157713669","market":"us","top_or_hot":-1,"title":"BOAN Biotech Schedules 27 Aug 2026 Board Meeting to Approve 1H26 Results and Assess Interim Dividend","media":"Bulletin Express","content":"<p>Shandong Boan Biotechnology Co., Ltd. (BOAN Biotech) has announced that its board of directors will convene on 27 August 2026 to review and approve the company’s interim financial results for the six months ended 30 June 2026. The agenda also includes deliberation on the declaration of an interim dividend, if any.</p>\n<p>The notice, dated 14 August 2026 and signed by Chairlady and CEO Jiang Hua, confirms that decisions regarding the interim results release and potential dividend distribution will be finalized at this meeting. Investors should expect publication of the approved interim report following the board’s deliberations.</p>\n<p>The current Board comprises two executive directors (Jiang Hua and Wang Shenghan), three non-executive directors (Liu Yuanchong, Li Li and Li Shixu), and three independent non-executive directors (Professor Shi Luwen, Dai Jixiong and Dr. Yu Jialin).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BOAN Biotech Schedules 27 Aug 2026 Board Meeting to Approve 1H26 Results and Assess Interim Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBOAN Biotech Schedules 27 Aug 2026 Board Meeting to Approve 1H26 Results and Assess Interim Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-14 22:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shandong Boan Biotechnology Co., Ltd. (BOAN Biotech) has announced that its board of directors will convene on 27 August 2026 to review and approve the company’s interim financial results for the six months ended 30 June 2026. The agenda also includes deliberation on the declaration of an interim dividend, if any.</p>\n<p>The notice, dated 14 August 2026 and signed by Chairlady and CEO Jiang Hua, confirms that decisions regarding the interim results release and potential dividend distribution will be finalized at this meeting. Investors should expect publication of the approved interim report following the board’s deliberations.</p>\n<p>The current Board comprises two executive directors (Jiang Hua and Wang Shenghan), three non-executive directors (Liu Yuanchong, Li Li and Li Shixu), and three independent non-executive directors (Professor Shi Luwen, Dai Jixiong and Dr. Yu Jialin).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06955","symbol_name":"博安生物","start_time":0,"source_url":"","article_id":"1157713669","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1157713669","pubTimestamp":1786717562,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shandong Boan Biotechnology Co., Ltd. (BOAN Biotech) has announced that its board of directors will convene on 27 August 2026 to review and approve the company’s interim financial results for the six...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06955":"博安生物"},"translate_title":"博安生物定于 2026 年 8 月 27 日召开董事会会议，批准 26 年上半年业绩并评估中期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06955":1},"content_text":"Shandong Boan Biotechnology Co., Ltd. (BOAN Biotech) has announced that its board of directors will convene on 27 August 2026 to review and approve the company’s interim financial results for the six months ended 30 June 2026. The agenda also includes deliberation on the declaration of an interim dividend, if any.\nThe notice, dated 14 August 2026 and signed by Chairlady and CEO Jiang Hua, confirms that decisions regarding the interim results release and potential dividend distribution will be finalized at this meeting. Investors should expect publication of the approved interim report following the board’s deliberations.\nThe current Board comprises two executive directors (Jiang Hua and Wang Shenghan), three non-executive directors (Liu Yuanchong, Li Li and Li Shixu), and three independent non-executive directors (Professor Shi Luwen, Dai Jixiong and Dr. Yu Jialin).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}